IP Library Patent Application 17420507
Patent Application
App. No. 17/420,507

NANOPARTICLES AND PREPARATION METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/420,507
Abstract

The present invention relates to nanoparticles of a metal chosen from among platinum, bismuth or a mixture thereof, which are functionalised at their surface by functionalised polyethylene glycol, comprising in particular at least one OH, COOH, NH 2 or SH functional group, and to their method of preparation, which comprises of the following steps: a) Mixing a precursor of nanoparticles with a functionalised polyethylene glycol, in particular comprising at least one OH, COOH, NH 2 or SH functional group, in water; b) Exposing the mixture to ionising radiation.

Claims (25)

1 . Nanoparticles of a metal chosen from among platinum, gold or bismuth, or one of the mixtures thereof, which are functionalised at their surface with functionalised polyethylene glycol.

2 . A nanoparticle preparation method for preparing nanoparticles of a metal chosen from among platinum, gold or bismuth, or a mixture thereof, the method comprising:

a) mixing a precursor of nanoparticles with a functionalised polyethylene glycol comprising at least one OH, COOH, NH 2 or SH functional group, in water; and

b) exposing the mixture to ionizing radiation.

3 . A method according to claim 2 , wherein the ionizing radiation is chosen from gamma radiation deriving from a source of Cobalt 60 or Cesium 137, electrons or accelerated ions.

4 . A method according to claim 2 , i wherein the step of exposing extends over a period of time between 1 and 20 hours for a dose of 10 kGy applied with a source of gamma radiation from a Co 60 source having a dose rate of about 95.5 Gy/min in order to completely reduce 10 −3 mol/L −1 of platinum complex.

5 . A method according to claim 2 , wherein the functionalised polyethylene is chosen from among Hydroxyl poly(ethylene glycol) [PEG-OH], Poly(ethylene glycol) diamine [PEG-2NH 2 ], α-hydroxyl-ω-carboxyl poly(ethylene glycol) [HO-PEG-COOH], and PEG-thiol [PEG-SH].

6 . A method according to claim 2 , wherein the precursor is used in implementation in an amount ranging from 10 −4 to 10 −2 mol/L, in terms of molar concentration of the total mixture of step a) and/or the functionalised polyethylene glycol is used in implementation in an amount ranging from 10 −3 to 10 −1 mol/L, in terms of molar concentration of the total mixture of step a).

7 . A method according to claim 2 , wherein the molar ratio between the precursor and the functionalised polyethylene glycol is between 10 and 100.

8 . A method according to claim 2 , that is carried out in the absence of any solvent other than water.

9 . (canceled)

10 . (canceled)

11 . The method according to claim 4 , wherein the period of time is between 1 and 2 hours.

12 . A nanoparticle according to claim 1 , wherein the functionalised polyethylenes are chosen from among Hydroxyl poly(ethylene glycol) [PEG-OH], Poly(ethylene glycol) diamine [PEG-2NH 2 ], α-hydroxyl-ω-carboxyl poly(ethylene glycol) [HO-PEG-COOH], and PEG-thiol [PEG-SH].

13 . Method for the treatment of cancers and tumours and/or for amplifying the effects of medical radiation used for the treatment of cancers or tumours, comprising administering to a patient in need thereof a therapeutically effective amount of a nanoparticle according to claim 1 .

14 . Method for the treatment of cancers and tumours and/or for amplifying the effects of medical radiation used for the treatment of cancers or tumours, comprising administering to a patient in need thereof a therapeutically effective amount of a nanoparticle obtainable by the method of claim 2 .

15 . Method for medical imaging for diagnostics in a subject in need thereof, comprising

administering the nanoparticle of claim 1 to the subject, and

performing the medical imaging on the subject.

16 . Method for medical imaging for diagnostics in a subject in need thereof, comprising

administering to the subject a nanoparticle obtainable by the method of claim 2 , and

performing the medical imaging on the subject.

17 . The method of claim 15 , wherein the medical imaging is performed by computed tomography (CT).

18 . The method of claim 15 , wherein the medical imaging is performed by computed tomography (CT).

19 . The nanoparticles of claim 1 , wherein the functionalised polyethylene glycol comprises at least one OH, COOH, NH 2 or SH functional group.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2025
From: SALADO LEZA, DANIELA EDITH; REMITA, HYND; PORCEL, ERIKA
To: UNIVERSITE PARIS-SACLAY; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 069765/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2025
From: LACOMBE, SANDRINE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 069765/0154 →
CHANGE OF ADDRESS Recorded Oct 21, 2022
From: UNIVERSITE PARIS-SACLAY
To: UNIVERSITE PARIS-SACLAY
Reel/Frame 061736/0969 →